PharmaShots | Incisive News in 3 Shots

Subscribe Now

Final Recommendation

NICE Publishes Final Recommendation for Almirall's Ilumetri (tildrakizumab) to Treat Moderate-To-Severe Plaque Psoriasis in Adults

NICE Publishes Final Recommendation for Almirall's Ilumetri (tildrakizumab) to Treat Moderate-To-Severe Plaque Psoriasis in Adults

April 19, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us